PMSNF (Proteome Sciences) EPS without NRI: $-0.01 (TTM As of Dec. 2025)


What is Proteome Sciences EPS without NRI?

Proteome Sciences PMSNF EPS without NRI is $-0.01 as of Dec. 2025. The stock has 6 warning signs investors should review. Among 161 Medical Diagnostics & Research companies, Proteome Sciences ranks worse than 621117.39% on this metric.

Proteome Sciences's earnings per share without non-recurring items for the six months ended in Dec. 2025 was $-0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Proteome Sciences's EPS without NRI or its related term are showing as below:

During the past 13 years, Proteome Sciences's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 58.70% per year. The lowest was -32.20% per year. And the median was 8.50% per year.

PMSNF's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 10.8
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Proteome Sciences's EPS (Diluted) for the six months ended in Dec. 2025 was $-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.01.

Proteome Sciences's EPS (Basic) for the six months ended in Dec. 2025 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.01.


Proteome Sciences  (OTCPK:PMSNF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Proteome Sciences EPS without NRI Related Terms


Proteome Sciences EPS without NRI Historical Data

* Premium members only.

The historical data trend for Proteome Sciences's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteome Sciences EPS without NRI Chart

Proteome Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.01 -0.01 -0.02 -0.01

Proteome Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 -0.00

PMSNF vs TMO, DHR, IDXX: EPS without NRI Comparison

For the Diagnostics & Research subindustry, Proteome Sciences's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteome Sciences PE Ratio without NRI vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Proteome Sciences's PE Ratio without NRI falls into.



Proteome Sciences EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-0.01 mean?
Proteome Sciences (PMSNF) has a EPS without NRI of $-0.01 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Proteome Sciences and its competitors. According to the industry distribution chart, Proteome Sciences ranks #999999 out of 161 companies in the Medical Diagnostics & Research industry.
Is Proteome Sciences' EPS without NRI too high?
Proteome Sciences' current EPS without NRI is $-0.01. Based on the distribution chart, Proteome Sciences ranks #999999 out of 161 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Proteome Sciences' EPS without NRI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Proteome Sciences ranks #999999 out of 161 companies for EPS without NRI. This places Proteome Sciences in the lower half of its industry. The industry median EPS without NRI is 10.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.80, based on 161 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Proteome Sciences and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proteome Sciences's current EPS without NRI is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Proteome Sciences (PMSNF) has a current EPS without NRI of $-0.01. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 17.5% below its estimated fair value. The current EPS without NRI is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Proteome Sciences (PMSNF), the current EPS without NRI is $-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proteome Sciences Business Description

Other Exchanges PRMl:UKPRM:UKPI2:Germany
Address Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.